PL416749A1 - Zastosowanie kationowej pochodnej dekstranu do hamowania replikacji wirusa HSV-1 - Google Patents

Zastosowanie kationowej pochodnej dekstranu do hamowania replikacji wirusa HSV-1

Info

Publication number
PL416749A1
PL416749A1 PL416749A PL41674916A PL416749A1 PL 416749 A1 PL416749 A1 PL 416749A1 PL 416749 A PL416749 A PL 416749A PL 41674916 A PL41674916 A PL 41674916A PL 416749 A1 PL416749 A1 PL 416749A1
Authority
PL
Poland
Prior art keywords
hsv
application
dextrane
retardation
viral replication
Prior art date
Application number
PL416749A
Other languages
English (en)
Other versions
PL235490B1 (pl
Inventor
Maria Nowakowska
Krzysztof Pyrć
Krzysztof Szczubiałka
Justyna Ciejka
Aleksandra Milewska
Magdalena Pachota
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL416749A priority Critical patent/PL235490B1/pl
Priority to PCT/IB2017/051918 priority patent/WO2017175132A1/en
Publication of PL416749A1 publication Critical patent/PL416749A1/pl
Publication of PL235490B1 publication Critical patent/PL235490B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie kationowo modyfikowanego za pomocą czwartorzędowych grup amoniowych dekstranu o wzorze I do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1, przy czym dekstran jest zmodyfikowany przy pomocy chlorku glicydylotrimetyloamoniowego (GTMAC).
PL416749A 2016-04-04 2016-04-04 Kationowa pochodna dekstranu do zastosowania w hamowaniu replikacji wirusa HSV-1 PL235490B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL416749A PL235490B1 (pl) 2016-04-04 2016-04-04 Kationowa pochodna dekstranu do zastosowania w hamowaniu replikacji wirusa HSV-1
PCT/IB2017/051918 WO2017175132A1 (en) 2016-04-04 2017-04-04 The use of cationic derivative of dextran for inhibition of herpes simplex viruses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL416749A PL235490B1 (pl) 2016-04-04 2016-04-04 Kationowa pochodna dekstranu do zastosowania w hamowaniu replikacji wirusa HSV-1

Publications (2)

Publication Number Publication Date
PL416749A1 true PL416749A1 (pl) 2017-10-09
PL235490B1 PL235490B1 (pl) 2020-08-24

Family

ID=58668929

Family Applications (1)

Application Number Title Priority Date Filing Date
PL416749A PL235490B1 (pl) 2016-04-04 2016-04-04 Kationowa pochodna dekstranu do zastosowania w hamowaniu replikacji wirusa HSV-1

Country Status (2)

Country Link
PL (1) PL235490B1 (pl)
WO (1) WO2017175132A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424871A1 (pl) * 2018-03-13 2019-09-23 Uniwersytet Jagielloński Zastosowanie kopolimerów do wytwarzania preparatu do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0066379A3 (en) 1981-05-15 1983-06-08 Riker Laboratories, Inc. Composition for combating herpes virus
AU2443299A (en) 1998-10-26 2000-05-15 Elena Alexandrovna Izaxon Dextran-containing biologically active substance
WO2006090365A2 (en) * 2005-02-22 2006-08-31 Yissum Research Development Company Polysaccharide-oligoamine conjugates as anti-amyloid and anti-viral agents
PL224855B1 (pl) * 2010-04-22 2017-02-28 Univ Jagielloński Zastosowanie modyfikowanych polisacharydów do neutralizacji heparyny

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL424871A1 (pl) * 2018-03-13 2019-09-23 Uniwersytet Jagielloński Zastosowanie kopolimerów do wytwarzania preparatu do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1

Also Published As

Publication number Publication date
PL235490B1 (pl) 2020-08-24
WO2017175132A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
BR112017020149A8 (pt) Derivados de maitansinoide, conjugados dos mesmos e métodos de uso
BR112018070859A2 (pt) degradantes da proteína de bet
BR112018014759A2 (pt) derivados de maitansinoide, conjugados dos mesmos e métodos de uso
MX2019009443A (es) Metodos para tratar la influenza.
BR112018012164A2 (pt) anticorpos neutralizantes do vírus da imunodeficiência humana
BR112017025892A2 (pt) vetores de vírus adeno-associados para o tratamento de mucolopissacaridoses
MX2019002541A (es) Derivados de pirimidina contra virus de la influenza.
SV2018005610A (es) Derivados de oxopiridina sustituidos
MX2021007679A (es) Anticuerpos humanos para hemaglutinina de influenza.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
BR112018069601A2 (pt) derivados de indolina substituídos como inibidores da replicação viral da dengue
BR112017023904A2 (pt) derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue
BR112017012402A2 (pt) derivados de 2,4-dioxo-quinazolina-6-sulfonamida como inibidores de parg
BR112018068956A2 (pt) derivados do composto indol substituídos como inibidores da replicação viral da dengue
EA201690093A1 (ru) Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний
BR112016025819A2 (pt) vetores de vírus adeno-associados para o tratamento de doenças de depósito lisossômico
EA201892219A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA201892802A1 (ru) Производные аденозина для применения при лечении рака
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
BR112018014794A2 (pt) pirimidinas substituídas com arila para uso em infecção pelo vírus influenza
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
BR112017001334A2 (pt) compostos de imidazopiridazina, seu uso e composição farmacêutica que os compreende
EA201891644A1 (ru) Антибактериальные соединения и их применение
EA201691566A1 (ru) Применение производных пиридазина для предупреждения или лечения атаксического синдрома
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais